Sign up here to receive news updates via email.
-
January 1, 1970 |
Media, Press Releases
BERG Forms Research Collaboration With Boehringer Ingelheim To Identify Candidate Biomarkers For A Group Of Inflammatory Conditions
read moreBERG will pair its Interrogative Biology® Platform with Boehringer Ingelheim’s Translational Medicine and Biomarker Expertise News provided by BERG Health May 06, 2020, 09:00 ET FRAMINGHAM, Mass., May 6, 2020 /PRNewswire/ — BERG, a clinical-stage biotech company that uses artificial intelligence (AI) to research diseases and develop innovative treatments, today announced a new collaboration with…
-
|
Media, Press Releases
BERG Forms Research Collaboration With Boehringer Ingelheim To Identify Candidate Biomarkers For A Group Of Inflammatory Conditions
read moreBERG will pair its Interrogative Biology® Platform with Boehringer Ingelheim’s Translational Medicine and Biomarker Expertise News provided by BERG Health May 06, 2020, 09:00 ET FRAMINGHAM, Mass., May 6, 2020 /PRNewswire/ — BERG, a clinical-stage biotech company that uses artificial intelligence (AI) to research diseases and develop innovative treatments, today announced a new collaboration with…
-
|
Media, Press Releases
BERG Forms Research Collaboration With Boehringer Ingelheim To Identify Candidate Biomarkers For A Group Of Inflammatory Conditions
read moreBERG will pair its Interrogative Biology® Platform with Boehringer Ingelheim’s Translational Medicine and Biomarker Expertise News provided by BERG Health May 06, 2020, 09:00 ET FRAMINGHAM, Mass., May 6, 2020 /PRNewswire/ — BERG, a clinical-stage biotech company that uses artificial intelligence (AI) to research diseases and develop innovative treatments, today announced a new collaboration with…
-
|
Media, Press Releases
BERG Presents Results of Phase 1 Clinical Study in Glioblastoma at 2020 American Society of Clinical Oncology (ASCO) Meeting
read moreBERG will pair its Interrogative Biology® Platform with Boehringer Ingelheim’s Translational Medicine and Biomarker Expertise News provided by BERG Health May 06, 2020, 09:00 ET FRAMINGHAM, Mass., May 6, 2020 /PRNewswire/ — BERG, a clinical-stage biotech company that uses artificial intelligence (AI) to research diseases and develop innovative treatments, today announced a new collaboration with…
-
|
Media, Press Releases
BERG Announces Presentation Of Multiple Interrogative Biology Platform® And Outputs From Multiple Collaborations At AACR
read moreNews provided by BERG Health Jun 22, 2020, 09:00 ET FRAMINGHAM, Mass., June 22, 2020 /PRNewswire/ — BERG, a clinical-stage biotech that employs artificial intelligence (AI) to research diseases and develop innovative treatments, today announced five presentations at the American Association for Cancer Research (AACR) Virtual Annual Meeting, being held from June 22- 24, 2020. Two…
-
|
Media, Press Releases
BERG to Present Latest Research to Improve Pancreatic Treatment at The European Society for Medical Oncology (ESMO) 2021 Congress
read moreResearch will unveil cutting-edge technology to improve the lives of patients suffering from this deadly disease News provided by BERG Health Sep 16, 2021, 09:01 ET FRAMINGHAM, Mass., Sept. 16, 2021 /PRNewswire/ — BERG, a clinical-stage biotech that employs patient biology and artificial intelligence (AI) to research diseases and develop innovative treatments, today…
